Patent Assignment
Reel/Frame 061434/0749
Merger
Recorded: 2022-09-15
Pages: 9
Assignor
PROTIVA BIOTHERAPEUTICS, INC.
Executed: 2018-01-01
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Lipid Containing Formulations
Application:
17/863,885 →
Publication:
US 2023/0174459
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 9, 2022
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; AKINC, AKIN; NAIR, JAYAPRAKASH K.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 060760/0007 →
Assignment of Assignor's Interest
Sep 1, 2022
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 060964/0421 →
Change of Name
Sep 12, 2022
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 061063/0970 →